The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 14, 2023

Filed:

May. 04, 2017
Applicant:

Navigo Proteins Gmbh, Halle/Saale, DE;

Inventors:

Ulrich Haupts, Halle/Saale, DE;

Markus Liebscher, Halle/Saale, DE;

Erik Fiedler, Halle/Saale, DE;

Assignee:

Navigo Proteins GmbH, Halle/Saale, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/68 (2017.01); A61K 47/65 (2017.01); C07K 14/435 (2006.01); C07K 16/28 (2006.01); C07K 16/32 (2006.01); G01N 33/533 (2006.01);
U.S. Cl.
CPC ...
A61K 47/6889 (2017.08); A61K 47/65 (2017.08); C07K 14/435 (2013.01); C07K 16/2863 (2013.01); C07K 16/32 (2013.01); G01N 33/533 (2013.01); C07K 2317/92 (2013.01); C07K 2317/94 (2013.01); C07K 2319/00 (2013.01); C07K 2319/035 (2013.01); C07K 2319/30 (2013.01); C07K 2319/33 (2013.01); C07K 2319/70 (2013.01);
Abstract

The invention generally relates to targeted compounds for the site-specific coupling of chemical moieties. The present invention features a targeted compound for the coupling of chemical moieties comprising at least one targeting domain capable of binding a target, and at least one linking moiety of up to 80 amino acids, preferably alanine, proline, and serine, and at least one coupling site consisting of cysteine or a cysteine-rich peptide motif (CXC, CXXC, or CXXXC), and wherein said linking moiety connects the targeting domain and a coupling site and/or wherein a linking moiety connects two coupling sites. The invention further features fusion proteins with ubiquitin muteins (Affilin @) as targeting domain. The invention also relates to the use of the targeted compounds for medical applications, in treatment or diagnosis of diseases.


Find Patent Forward Citations

Loading…